Fighting to Expand Access to Quality Cancer Care
to save lives
We are a Patient-First Company innovating cancer care
Fighting to Expand Access to Quality Cancer Care
to save lives
We are a Patient-First Company innovating cancer care
We are building the first patient-centric integrated Tele-oncology platform for immediate access to oncologists and community support.
The road to quality cancer care goes through patient-centric care. Haploscope’s unique, innovative platform combines multiple end-to-end Tele-oncology solutions built onto a single platform, including decision support tools that drive earlier detection to intervene proactively. Increased access to cancer care that breaks down barriers saves lives.
People live in
counties in the uS without an Oncologist
out of pocket paid by 15 million uS Cancer patients in 2019
more oncologists in urban areas compared to rural areas
More than 73,000 African Americans died of cancer in the United States in 2019; African Americans have the highest death rate and shortest survival of any racial and ethnic group in the U.S. for most cancers.
Identifying cancer health disparities helps communities at the highest risk find the best ways to reduce cancer risk and improve preventive care and treatment access.
Patients have increased access to their oncologists in real-time
Cancer centers have immediate access to high risk patients while providing increased patient satisfaction
Insurance companies efficiently manage payments by decreasing avoidable costs
Continuity of Care & Fewer barriers to treatments
Reduce Exposure to Infections
Improve quality of life
Reduce cost by diverting patients away from alternative care setting by expanding access to patients
Patients save money by not having to pay for travel to and from a cancer center, which can be miles away for rural communities.
A Patient-First company
Cancer does not affect all people equally. As most oncologists are in big cities, the relative scarcity of oncologists in rural areas results in the rural population not receiving care from experts. The projected shortage of oncologists by 2050 will only increase cancer incidence, morbidity, and mortality. And the question arose - WHY IS THERE SUCH LIMITED ACCESS TO CANCER CARE?
In 2020, we embarked on our journey to build the world’s first comprehensive tele-oncology platform to increase access to quality care by innovating cancer care delivery. At Haploscope, our purpose is to improve patients’ lives every year, including those in underserved communities, by helping close disparity to reduce and ultimately eliminate differences in cancer incidence, morbidity, and mortality.
click here to apply for our early invitation program
apply below for our early invitation program
Haploscope is the FIRST technology infrastructure for cancer care in the form of a Tele oncology platform to improve the speed of care through our unique, secure, and innovative offering. We combine multiple telehealth capabilities onto a single, integrated system to help increase early cancer detection and proactively intervene to save lives.
Our enterprise solution was designed with the patients and oncologists in mind. Simple to use and designed to integrate with HIT systems for seamless user adoption while launching virtual care right from your EHR or existing solutions with FHIR HL7.
Our goal is to help oncologists prioritze how efficiently a patient is treated and not how the care is delivered.
Join our mission to accelerate access to cancer care beyond borders and physical separation.
Please provide your information for early access to our community, tele-oncology platform, and physician portal.
